everything you ever wanted to know about pros (and perhaps even more) amylou c. dueck, phd mayo...

28
Everything You Ever Everything You Ever Wanted to Know Wanted to Know About PROs About PROs (and Perhaps Even (and Perhaps Even More) More) Amylou C. Dueck, PhD Amylou C. Dueck, PhD Mayo Clinic Arizona & Mayo Clinic Arizona & NCCTG NCCTG CRA Workshop for Cancer Control Studies CRA Workshop for Cancer Control Studies November 14, 2009 November 14, 2009

Upload: savannah-watkins

Post on 26-Mar-2015

219 views

Category:

Documents


2 download

TRANSCRIPT

Page 1: Everything You Ever Wanted to Know About PROs (and Perhaps Even More) Amylou C. Dueck, PhD Mayo Clinic Arizona & NCCTG CRA Workshop for Cancer Control

Everything You Ever Everything You Ever Wanted to Know Wanted to Know

About PROsAbout PROs(and Perhaps Even More)(and Perhaps Even More)

Amylou C. Dueck, PhDAmylou C. Dueck, PhDMayo Clinic Arizona &Mayo Clinic Arizona &

NCCTGNCCTG

CRA Workshop for Cancer Control StudiesCRA Workshop for Cancer Control StudiesNovember 14, 2009November 14, 2009

Page 2: Everything You Ever Wanted to Know About PROs (and Perhaps Even More) Amylou C. Dueck, PhD Mayo Clinic Arizona & NCCTG CRA Workshop for Cancer Control

OutlineOutline What are PROs?What are PROs? What are the different types of PROs?What are the different types of PROs? Why do we measure PROs?Why do we measure PROs? How do we measure PROs?How do we measure PROs? Why do we measure PROs the way that we do?Why do we measure PROs the way that we do? Why are there different instruments measuring the same Why are there different instruments measuring the same

thing?thing? How are these measures created?How are these measures created? What can PROs tell us?What can PROs tell us? Why is it so important that they be administered as specified Why is it so important that they be administered as specified

in protocols?in protocols? Why is the CRA role so important?Why is the CRA role so important? Are there respondent burden issues?Are there respondent burden issues?

Page 3: Everything You Ever Wanted to Know About PROs (and Perhaps Even More) Amylou C. Dueck, PhD Mayo Clinic Arizona & NCCTG CRA Workshop for Cancer Control

What are PROs?What are PROs? PRO = Patient-reported outcomePRO = Patient-reported outcome

Definition from FDA Draft Guidance:Definition from FDA Draft Guidance: ““a measurement of any aspect of a patient’s health status that a measurement of any aspect of a patient’s health status that

comes directly from the patient (i.e., without the interpretation of comes directly from the patient (i.e., without the interpretation of the patient’s responses by a physician or anyone else).”the patient’s responses by a physician or anyone else).”

http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm071975.pdf

Or Google “FDA draft guidance patient reported-outcomes”Or Google “FDA draft guidance patient reported-outcomes”

Definition from Wikipedia:Definition from Wikipedia: ““PRO is an umbrella term that covers a whole range of potential PRO is an umbrella term that covers a whole range of potential

types of measurement but is used specifically to refer to types of measurement but is used specifically to refer to questionnaires completed by the patient.”questionnaires completed by the patient.”

http://en.wikipedia.org/wiki/Patient-reported_outcomehttp://en.wikipedia.org/wiki/Patient-reported_outcome

Page 4: Everything You Ever Wanted to Know About PROs (and Perhaps Even More) Amylou C. Dueck, PhD Mayo Clinic Arizona & NCCTG CRA Workshop for Cancer Control

What are the different types of What are the different types of PROs?PROs?

Health-related quality of life (HRQOL)Health-related quality of life (HRQOL) Quality of life (QOL)Quality of life (QOL) SymptomsSymptoms FunctioningFunctioning SatisfactionSatisfaction Decision-making / preferencesDecision-making / preferences Treatment complianceTreatment compliance Health utilitiesHealth utilities Others???Others???

Page 5: Everything You Ever Wanted to Know About PROs (and Perhaps Even More) Amylou C. Dueck, PhD Mayo Clinic Arizona & NCCTG CRA Workshop for Cancer Control

Why do we measure PROs?Why do we measure PROs?

PROs are key to providing a better PROs are key to providing a better understanding of treatment outcomes, beyond understanding of treatment outcomes, beyond the data obtained from clinical assessmentsthe data obtained from clinical assessments

PROs have become to gold standard for PROs have become to gold standard for assessing subjective experiences of patientsassessing subjective experiences of patients

To get the patient’s perspective!To get the patient’s perspective!

Page 6: Everything You Ever Wanted to Know About PROs (and Perhaps Even More) Amylou C. Dueck, PhD Mayo Clinic Arizona & NCCTG CRA Workshop for Cancer Control

How do we measure PROs?How do we measure PROs?INSTRUMENTSINSTRUMENTS

European Organisation for Research and Treatment of Cancer European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30)Quality of Life Questionnaire Core 30 (EORTC QLQ-C30) Disease modules such as the Breast (BR23)Disease modules such as the Breast (BR23) http://groups.eortc.be/qol/index.htmhttp://groups.eortc.be/qol/index.htm

http://www.mdanderson.org/education-and-research/departments-http://www.mdanderson.org/education-and-research/departments-programs-and-labs/departments-and-divisions/symptom-research/programs-and-labs/departments-and-divisions/symptom-research/symptom-assessment-tools/index.htmlsymptom-assessment-tools/index.html Brief Pain Inventory (BPI)Brief Pain Inventory (BPI) Brief Fatigue Inventory (BFI)Brief Fatigue Inventory (BFI) MD Anderson Symptom Inventory (MDASI)MD Anderson Symptom Inventory (MDASI)

Functional Assessment of Cancer Therapy General (FACT-G)Functional Assessment of Cancer Therapy General (FACT-G) Disease specific (FACT-B), disease/symptom specific (FBSI), Disease specific (FACT-B), disease/symptom specific (FBSI),

symptom specific (FACT-An), treatment specific (FACT-Taxane)symptom specific (FACT-An), treatment specific (FACT-Taxane) http://www.facit.org/http://www.facit.org/

Page 7: Everything You Ever Wanted to Know About PROs (and Perhaps Even More) Amylou C. Dueck, PhD Mayo Clinic Arizona & NCCTG CRA Workshop for Cancer Control

How do we measure PROs?How do we measure PROs?INSTRUMENT REPOSITORIESINSTRUMENT REPOSITORIES

Databases of instrumentsDatabases of instruments QOLIDQOLID

http://www.proqolid.org/http://www.proqolid.org/ OLGAOLGA

http://www.olga-qol.com/index.htmlhttp://www.olga-qol.com/index.html Australian Centre on Quality of LifeAustralian Centre on Quality of Life

http://acqol.deakin.edu.au/instruments/index.htmhttp://acqol.deakin.edu.au/instruments/index.htm American Thoracic Society Quality of Life ResourceAmerican Thoracic Society Quality of Life Resource

http://www.atsqol.org/sections/instruments/http://www.atsqol.org/sections/instruments/index.htmlindex.html

Page 8: Everything You Ever Wanted to Know About PROs (and Perhaps Even More) Amylou C. Dueck, PhD Mayo Clinic Arizona & NCCTG CRA Workshop for Cancer Control

EORTC QLQ-C30EORTC QLQ-C30

Page 9: Everything You Ever Wanted to Know About PROs (and Perhaps Even More) Amylou C. Dueck, PhD Mayo Clinic Arizona & NCCTG CRA Workshop for Cancer Control

EQ-5D

Page 10: Everything You Ever Wanted to Know About PROs (and Perhaps Even More) Amylou C. Dueck, PhD Mayo Clinic Arizona & NCCTG CRA Workshop for Cancer Control

Brief Pain Inventory Short Form

Page 11: Everything You Ever Wanted to Know About PROs (and Perhaps Even More) Amylou C. Dueck, PhD Mayo Clinic Arizona & NCCTG CRA Workshop for Cancer Control
Page 12: Everything You Ever Wanted to Know About PROs (and Perhaps Even More) Amylou C. Dueck, PhD Mayo Clinic Arizona & NCCTG CRA Workshop for Cancer Control

Wong-Baker FACES Pain ScaleWong-Baker FACES Pain Scale

Page 13: Everything You Ever Wanted to Know About PROs (and Perhaps Even More) Amylou C. Dueck, PhD Mayo Clinic Arizona & NCCTG CRA Workshop for Cancer Control

How do we measure PROs?How do we measure PROs?MODES OF ADMINISTRATIONMODES OF ADMINISTRATION

PaperPaper In clinicIn clinic Take-homeTake-home

Interview (in person)Interview (in person) Interview (telephone)Interview (telephone) ePROs (electronic data capture of PROs)ePROs (electronic data capture of PROs)

Digital penDigital pen Wireless tabletWireless tablet Smart phoneSmart phone Telephone = Interactive Voice Response System (IVRS)Telephone = Interactive Voice Response System (IVRS) WebWeb

Page 14: Everything You Ever Wanted to Know About PROs (and Perhaps Even More) Amylou C. Dueck, PhD Mayo Clinic Arizona & NCCTG CRA Workshop for Cancer Control

PaperPaper

Page 15: Everything You Ever Wanted to Know About PROs (and Perhaps Even More) Amylou C. Dueck, PhD Mayo Clinic Arizona & NCCTG CRA Workshop for Cancer Control

WebWeb

Page 16: Everything You Ever Wanted to Know About PROs (and Perhaps Even More) Amylou C. Dueck, PhD Mayo Clinic Arizona & NCCTG CRA Workshop for Cancer Control

IVRS: http://www.perceptive.com/files/flash/diary2.swfIVRS: http://www.perceptive.com/files/flash/diary2.swf

Page 17: Everything You Ever Wanted to Know About PROs (and Perhaps Even More) Amylou C. Dueck, PhD Mayo Clinic Arizona & NCCTG CRA Workshop for Cancer Control

Wireless tabletWireless tablet

http://www.invivodata.com/media/swf/Demo.swfhttp://www.invivodata.com/media/swf/Demo.swf

Page 18: Everything You Ever Wanted to Know About PROs (and Perhaps Even More) Amylou C. Dueck, PhD Mayo Clinic Arizona & NCCTG CRA Workshop for Cancer Control

Why do we measure PROs the way Why do we measure PROs the way that we do?that we do?

Much work goes into instrument developmentMuch work goes into instrument development Need to make sure that the questionnaire is Need to make sure that the questionnaire is

measuring what you think it is measuringmeasuring what you think it is measuring Need to make sure that patients are interpreting Need to make sure that patients are interpreting

questions as intendedquestions as intended Need to make sure that the instrument is sensitive Need to make sure that the instrument is sensitive

to change (but also produces similar results if to change (but also produces similar results if nothing has changed)nothing has changed)

Need to know the size of a clinically meaningful Need to know the size of a clinically meaningful change or differencechange or difference

Page 19: Everything You Ever Wanted to Know About PROs (and Perhaps Even More) Amylou C. Dueck, PhD Mayo Clinic Arizona & NCCTG CRA Workshop for Cancer Control

Why are there different instruments Why are there different instruments measuring the same thing?measuring the same thing?

Independent groups developed instruments to Independent groups developed instruments to fit their own needsfit their own needs

Instruments vary in level of detail and Instruments vary in level of detail and intended populationintended population

Page 20: Everything You Ever Wanted to Know About PROs (and Perhaps Even More) Amylou C. Dueck, PhD Mayo Clinic Arizona & NCCTG CRA Workshop for Cancer Control

How are these measures created?How are these measures created?

May involve some or all of these steps:May involve some or all of these steps: Conceptual frameworkConceptual framework Item generation (literature, expert opinion, patient Item generation (literature, expert opinion, patient

focus groups, online chat rooms/blogs, etc.)focus groups, online chat rooms/blogs, etc.) Cognitive interviewsCognitive interviews Feasibility testingFeasibility testing Validation studyValidation study

Page 21: Everything You Ever Wanted to Know About PROs (and Perhaps Even More) Amylou C. Dueck, PhD Mayo Clinic Arizona & NCCTG CRA Workshop for Cancer Control

What can PROs tell us?What can PROs tell us?

Median Survival Median Survival (Months)(Months)

Median (95% CI)Median (95% CI)

Log-rankLog-rankP-valueP-value

QOL CDQOL CD 9.3 (8.1, 10.6)9.3 (8.1, 10.6)0.00010.0001

QOL nCDQOL nCD 16.8 (16.1, 17.4)16.8 (16.1, 17.4)

nCD

CD

Single-item overall QOL at baseline is prognostic of survival in cancer patients! Even after adjusting for performance status!

Tan AD, Novotny PJ, et al. A patient-level meta-analytic investigation of the prognostic significance of baseline quality of life (QOL) for overall survival (OS) among 3,704 patients participating in 24 North Central Cancer Treatment Group (NCCTG) and Mayo Clinic Cancer Center (MC) oncology clinical trials. J Clin Oncol 26: 2008 (May 20 suppl; abstr 9515), ASCO 2008.

Page 22: Everything You Ever Wanted to Know About PROs (and Perhaps Even More) Amylou C. Dueck, PhD Mayo Clinic Arizona & NCCTG CRA Workshop for Cancer Control

So is single-item fatigue! Even after So is single-item fatigue! Even after adjusting for overall QOL and adjusting for overall QOL and

performance status!performance status!

nCF

CF

0

10

20

30

40

50

60

70

80

90

100

0 1 2 3 4 5

Survival Time(Years)

% A

live

>83.9 (NA)

31.5 (25.9, 42.4)

Median Survival (Months)

Median (95% CI)

Fatigue nCF 0.0001Fatigue CF

Log-rankP-value

Sloan JA, Liu H, et al. A patient-level pooled analysis of the prognostic significance of baseline fatigue for overall survival (OS) among 3,915 patients participating in 43 North Central Cancer Treatment Group (NCCTG) and Mayo Clinic Cancer Center (MC) oncology clinical trials. J Clin Oncol 27:15s, 2009 (suppl; abstr 9599), ASCO 2009.

Page 23: Everything You Ever Wanted to Know About PROs (and Perhaps Even More) Amylou C. Dueck, PhD Mayo Clinic Arizona & NCCTG CRA Workshop for Cancer Control

Some things are just better Some things are just better measured by the patient!measured by the patient!

Hot flash studies (women and men)Hot flash studies (women and men) ““Aren’t hot flashes better measured by a device which Aren’t hot flashes better measured by a device which

measures skin conductance? How do you know that the patient measures skin conductance? How do you know that the patient is really having a hot flash?”is really having a hot flash?”

And in response, the famous words of one NCCTG And in response, the famous words of one NCCTG investigator: “I wouldn’t want to be the one to tell a woman investigator: “I wouldn’t want to be the one to tell a woman that she’s not having a hot flash.”that she’s not having a hot flash.”

Page 24: Everything You Ever Wanted to Know About PROs (and Perhaps Even More) Amylou C. Dueck, PhD Mayo Clinic Arizona & NCCTG CRA Workshop for Cancer Control

Mean Hot Flash Score Reduction Randomized Studies

0

20

40

60

80

100

0 1 2 3 4 5 6

Week

% R

edu

ctio

n (

Mea

n) Placebo (n=420)

Soy (n=78)

Clonidine (n=75)

Megestrol (n=74)

Fluoxetine (n=36)

Venlafaxine (n=48)

Vitamin E (n=53)

Black Cohosh (n=58)

Ven (vs MPA) (n=94)

MPA 400 mg (n=94)

MPA 500 mg X 3(n=7)

Loprinzi CL, Barton DL, et al. Mayo Clinic and North Central Cancer Treatment Group hot flash studies: a 20-year experience. Menopause 2008; 15(4):655-660.

Page 25: Everything You Ever Wanted to Know About PROs (and Perhaps Even More) Amylou C. Dueck, PhD Mayo Clinic Arizona & NCCTG CRA Workshop for Cancer Control

Why is it so important that they be Why is it so important that they be administered as specified in protocols?administered as specified in protocols?

May see things like:May see things like: Administer baseline patient assessment prior to notifying Administer baseline patient assessment prior to notifying

patient of his/her randomization assignmentpatient of his/her randomization assignment Administer onstudy patient assessment prior to discussing Administer onstudy patient assessment prior to discussing

outcome of disease assessmentoutcome of disease assessment Administer in a private room or a quite area in a waiting Administer in a private room or a quite area in a waiting

room with adequate privacyroom with adequate privacy Why?Why?

Avoid biasAvoid bias Increase compliance / patient willingnessIncrease compliance / patient willingness Consistency across sites, patients, visitsConsistency across sites, patients, visits

Page 26: Everything You Ever Wanted to Know About PROs (and Perhaps Even More) Amylou C. Dueck, PhD Mayo Clinic Arizona & NCCTG CRA Workshop for Cancer Control

Why is the CRA role so important?Why is the CRA role so important? I wouldn’t have any data without CRAs!I wouldn’t have any data without CRAs! Data quality and quantity is directly impacted by the Data quality and quantity is directly impacted by the

CRACRA Follow protocolFollow protocol

Administration guidelines and test scheduleAdministration guidelines and test schedule Check duplication quality of questionnairesCheck duplication quality of questionnaires

Missing pages?Missing pages? Professional-looking copies => better patient complianceProfessional-looking copies => better patient compliance

Answer patient questionsAnswer patient questions Even with ePROsEven with ePROs

AdministrationAdministration Patient questionsPatient questions

Page 27: Everything You Ever Wanted to Know About PROs (and Perhaps Even More) Amylou C. Dueck, PhD Mayo Clinic Arizona & NCCTG CRA Workshop for Cancer Control

Are there respondent burden issues?Are there respondent burden issues?

YES!!!YES!!! We’ve all filled out questionnaires from time We’ve all filled out questionnaires from time

to time – how long does the survey have to be to time – how long does the survey have to be for you to say “FORGET IT!”???for you to say “FORGET IT!”???

For cancer patients: For cancer patients: ≤50 items≤50 items

Page 28: Everything You Ever Wanted to Know About PROs (and Perhaps Even More) Amylou C. Dueck, PhD Mayo Clinic Arizona & NCCTG CRA Workshop for Cancer Control

Questions?Questions?

Contact info:Contact info:

Amylou DueckAmylou Dueck

[email protected]@mayo.edu